BR9912117A - Uso de estimulador de captação de glicose para reduzir a apoptose - Google Patents
Uso de estimulador de captação de glicose para reduzir a apoptoseInfo
- Publication number
- BR9912117A BR9912117A BR9912117-4A BR9912117A BR9912117A BR 9912117 A BR9912117 A BR 9912117A BR 9912117 A BR9912117 A BR 9912117A BR 9912117 A BR9912117 A BR 9912117A
- Authority
- BR
- Brazil
- Prior art keywords
- stimulator
- glucose uptake
- human
- reduce
- cells
- Prior art date
Links
- 230000006907 apoptotic process Effects 0.000 title abstract 3
- 230000004190 glucose uptake Effects 0.000 title abstract 2
- 210000002237 B-cell of pancreatic islet Anatomy 0.000 abstract 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 abstract 1
- 210000004413 cardiac myocyte Anatomy 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 abstract 1
- 210000002889 endothelial cell Anatomy 0.000 abstract 1
- 239000008103 glucose Substances 0.000 abstract 1
- 210000002569 neuron Anatomy 0.000 abstract 1
- 231100000252 nontoxic Toxicity 0.000 abstract 1
- 230000003000 nontoxic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Diabetes (AREA)
- Cardiology (AREA)
- Epidemiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Emergency Medicine (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9815872.8A GB9815872D0 (en) | 1998-07-21 | 1998-07-21 | Novel method |
| GBGB9815871.0A GB9815871D0 (en) | 1998-07-21 | 1998-07-21 | Novel compound |
| GBGB9905387.8A GB9905387D0 (en) | 1999-03-09 | 1999-03-09 | Novel method |
| PCT/GB1999/002361 WO2000004890A1 (en) | 1998-07-21 | 1999-07-21 | Use of glucose uptake enhancer for reducing apoptosis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR9912117A true BR9912117A (pt) | 2001-04-10 |
Family
ID=27269407
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR9912117-4A BR9912117A (pt) | 1998-07-21 | 1999-07-21 | Uso de estimulador de captação de glicose para reduzir a apoptose |
Country Status (25)
| Country | Link |
|---|---|
| EP (2) | EP1098639B1 (enExample) |
| JP (1) | JP2002521326A (enExample) |
| KR (1) | KR20010079551A (enExample) |
| CN (1) | CN1310620A (enExample) |
| AP (1) | AP2001002036A0 (enExample) |
| AT (1) | ATE288746T1 (enExample) |
| AU (1) | AU5053799A (enExample) |
| BG (1) | BG105250A (enExample) |
| BR (1) | BR9912117A (enExample) |
| CA (1) | CA2338211A1 (enExample) |
| DE (1) | DE69923687T2 (enExample) |
| DK (1) | DK1098639T3 (enExample) |
| EA (1) | EA200100165A1 (enExample) |
| ES (1) | ES2237929T3 (enExample) |
| HU (1) | HUP0103199A3 (enExample) |
| ID (1) | ID26986A (enExample) |
| IL (1) | IL140664A0 (enExample) |
| NO (1) | NO20010292L (enExample) |
| OA (1) | OA11579A (enExample) |
| PL (1) | PL345627A1 (enExample) |
| PT (1) | PT1098639E (enExample) |
| SI (1) | SI1098639T1 (enExample) |
| SK (1) | SK1012001A3 (enExample) |
| TR (1) | TR200100207T2 (enExample) |
| WO (1) | WO2000004890A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU3073600A (en) * | 1999-01-19 | 2000-08-07 | Sankyo Company Limited | Inhibitor for nerve cell death due to glutamic acid cytotoxicity |
| WO2001016120A1 (en) | 1999-08-27 | 2001-03-08 | Eli Lilly And Company | Biaryl-oxa(thia)zole derivatives and their use as ppars modulators |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3856378T2 (de) * | 1987-09-04 | 2000-05-11 | Beecham Group P.L.C., Brentford | Substituierte Thiazolidindionderivate |
| JPH05202042A (ja) * | 1992-01-24 | 1993-08-10 | Sankyo Co Ltd | 糖尿病性合併症治療剤 |
| GB9218830D0 (en) * | 1992-09-05 | 1992-10-21 | Smithkline Beecham Plc | Novel compounds |
| IL120443A (en) * | 1996-03-18 | 2000-07-16 | Sankyo Co | Use of an insulin sensitizer for the manufacture of a medicament for the treatment or prophylaxis of pancreatitis |
| GB9611947D0 (en) * | 1996-06-07 | 1996-08-07 | Glaxo Group Ltd | Medicaments |
| US6277819B1 (en) * | 1996-08-30 | 2001-08-21 | Eli Lilly And Company | Use of GLP-1 or analogs in treatment of myocardial infarction |
| CN1235543A (zh) * | 1996-09-12 | 1999-11-17 | 三共株式会社 | 含有曲格列酮的谷胱甘肽还原酶活性增强剂 |
| GB9721692D0 (en) * | 1997-10-13 | 1997-12-10 | Smithkline Beecham Plc | Novel treatment |
| DE69834508T2 (de) * | 1997-11-19 | 2006-11-23 | Takeda Pharmaceutical Co. Ltd. | Apoptoseinhibitoren |
| WO1999043326A1 (en) * | 1998-02-24 | 1999-09-02 | The Trustees Of The University Of Pennsylvania | Use of a cardiac purinoceptor to effect cellular glucose uptake |
| WO1999059586A1 (en) * | 1998-05-19 | 1999-11-25 | Regents Of The University Of California | Thiazolidine and oxazolidine derivatives for the treatment of acute myocardial infarction and inhibition of cardiomyocyte apoptosis |
| US5968960A (en) * | 1999-01-14 | 1999-10-19 | The Regents Of The University Of California | Use of thiazolidinediones to ameliorate the adverse consequences of myocardial ischemia on myocardial function and metabolism |
-
1999
- 1999-07-21 SI SI9930772T patent/SI1098639T1/xx unknown
- 1999-07-21 SK SK101-2001A patent/SK1012001A3/sk unknown
- 1999-07-21 EP EP99934914A patent/EP1098639B1/en not_active Expired - Lifetime
- 1999-07-21 CN CN99808983A patent/CN1310620A/zh active Pending
- 1999-07-21 IL IL14066499A patent/IL140664A0/xx unknown
- 1999-07-21 PL PL99345627A patent/PL345627A1/xx not_active Application Discontinuation
- 1999-07-21 PT PT99934914T patent/PT1098639E/pt unknown
- 1999-07-21 EA EA200100165A patent/EA200100165A1/ru unknown
- 1999-07-21 ID IDW20010150A patent/ID26986A/id unknown
- 1999-07-21 ES ES99934914T patent/ES2237929T3/es not_active Expired - Lifetime
- 1999-07-21 AU AU50537/99A patent/AU5053799A/en not_active Abandoned
- 1999-07-21 DK DK99934914T patent/DK1098639T3/da active
- 1999-07-21 TR TR2001/00207T patent/TR200100207T2/xx unknown
- 1999-07-21 EP EP04078537A patent/EP1516617A2/en not_active Withdrawn
- 1999-07-21 CA CA002338211A patent/CA2338211A1/en not_active Abandoned
- 1999-07-21 AP APAP/P/2001/002036A patent/AP2001002036A0/en unknown
- 1999-07-21 OA OA1200100010A patent/OA11579A/en unknown
- 1999-07-21 WO PCT/GB1999/002361 patent/WO2000004890A1/en not_active Ceased
- 1999-07-21 DE DE69923687T patent/DE69923687T2/de not_active Expired - Fee Related
- 1999-07-21 BR BR9912117-4A patent/BR9912117A/pt not_active IP Right Cessation
- 1999-07-21 HU HU0103199A patent/HUP0103199A3/hu unknown
- 1999-07-21 AT AT99934914T patent/ATE288746T1/de not_active IP Right Cessation
- 1999-07-21 JP JP2000560883A patent/JP2002521326A/ja active Pending
- 1999-07-21 KR KR1020017000925A patent/KR20010079551A/ko not_active Withdrawn
-
2001
- 2001-01-18 NO NO20010292A patent/NO20010292L/no unknown
- 2001-02-14 BG BG105250A patent/BG105250A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ATE288746T1 (de) | 2005-02-15 |
| AP2001002036A0 (en) | 2001-03-31 |
| HUP0103199A2 (hu) | 2002-05-29 |
| KR20010079551A (ko) | 2001-08-22 |
| EA200100165A1 (ru) | 2001-08-27 |
| HUP0103199A3 (en) | 2002-08-28 |
| EP1098639B1 (en) | 2005-02-09 |
| CA2338211A1 (en) | 2000-02-03 |
| EP1098639A1 (en) | 2001-05-16 |
| OA11579A (en) | 2004-06-01 |
| PT1098639E (pt) | 2005-06-30 |
| DK1098639T3 (da) | 2005-06-13 |
| IL140664A0 (en) | 2002-02-10 |
| NO20010292D0 (no) | 2001-01-18 |
| DE69923687T2 (de) | 2006-04-06 |
| AU5053799A (en) | 2000-02-14 |
| DE69923687D1 (de) | 2005-03-17 |
| ID26986A (id) | 2001-02-22 |
| NO20010292L (no) | 2001-03-08 |
| SK1012001A3 (en) | 2001-08-06 |
| HK1037865A1 (en) | 2002-02-22 |
| PL345627A1 (en) | 2002-01-02 |
| WO2000004890A1 (en) | 2000-02-03 |
| EP1516617A2 (en) | 2005-03-23 |
| TR200100207T2 (tr) | 2001-05-21 |
| SI1098639T1 (enExample) | 2005-08-31 |
| CN1310620A (zh) | 2001-08-29 |
| ES2237929T3 (es) | 2005-08-01 |
| JP2002521326A (ja) | 2002-07-16 |
| BG105250A (en) | 2001-11-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK0839026T3 (da) | Micellære polyether-blokcopolymerkompositioner til målretning af biologiske midler | |
| DK0850068T3 (da) | Lipidekstrakt med antiinflammatorisk aktivitet | |
| BR9807577A (pt) | Método para prevenir e retardar o inìcio da doença de alzheimer e sua composição | |
| WO1999064059A3 (en) | Use of secretin for the treatment of autism and other neurological, behavioral and immunological disorders | |
| DE69932414D1 (de) | Indole-3-propionsäure, ihre salze und ester als arzneimittel | |
| EA200101089A1 (ru) | Новый способ лечения | |
| DK0998287T3 (da) | Anvendelse af levobupivacain | |
| ATE413179T1 (de) | Therapeutische verwendungen von steroiden bei blutzellmangelzustaenden | |
| DE69919179D1 (de) | Substituierte gamma-phenyl-delta-lactone und deren analoge, und ihre verwendungen | |
| MA26777A1 (fr) | Inhibiteurs d'aminotransferase dependante d'aminoacide en chaine ramifiee et leur usage dans le traitement de la retinopathie diabetique. | |
| NO870772D0 (no) | Vevplasminogenaktivator for normale humane tykktarmceller. | |
| DK1083929T3 (da) | Anvendelse af anabolske stoffer | |
| EA199800717A1 (ru) | Способ лечения заболеваний млекопитающих и цвиттерионная композиция | |
| BRPI0409699A (pt) | métodos de indução do efeito diurético, de indução, manutenção ou restauração do efeito diurético de diurético não modificador de adenosina, de manutenção, restauração ou melhoria da função renal em paciente, de indução de diurese, de prevenção do inìcio de deficiência renal em paciente com sobrecarga de fluidos ou chf, de tratamento de paciente que sofre de chf e de melhoria dos resultados globais da saúde, composição farmacêutica e seus usos | |
| WO2000030425A3 (en) | Method of using pon-1 to decrease atheroma formation | |
| HUP9802897A3 (en) | Optically active pyridyl-4h-1,2,4-oxadiazine derivatives, the use thereof in the treatment of vascular diseases and pharmaceutical composition containing the compound as active ingredient | |
| BR9912117A (pt) | Uso de estimulador de captação de glicose para reduzir a apoptose | |
| PT1058544E (pt) | Inibicao da actividade do tnf | |
| BR9708525A (pt) | Método de tratamento de insuficência cardíaca com antagonistas de endotelina | |
| FR2749514B1 (fr) | Systemes transdermiques renfermant 2 principes actifs dans des compartiments separes, leur procede de preparation et leur application comme medicament | |
| PT1007093E (pt) | Metodos para o tratamento de desordens atraves da utilizacao de interleucina-9 e seus antagonistas | |
| WO2003072606A3 (en) | Galectin-8and functional derivatives as binding agents for cd44 glycoproteins and methods of use | |
| PT711163E (pt) | Utilizacao de benzidamina no tratamento de estados patologicos provocados por tnf | |
| ATE306278T1 (de) | Behandlung von knochenleiden mit adrenomedullin | |
| DE69000791D1 (de) | Therapeutische mittel fuer metabolische knochenkrankheiten. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B25D | Requested change of name of applicant approved | ||
| B25G | Requested change of headquarter approved | ||
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 8A ANUIDADE. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1919 DE 16/10/2007. |